The IAM Strategy 300 focuses exclusively on patent practitioners and has firmly established itself as the definitive 'go-to' resource for those seeking world-class legal patent expertise.
Marco Stief is one of the leading individuals in Germany for patent strategy, particularly in the pharmaceutical field. Marco maintains one of the best Supplementary Protection Certificate practices in the country and is considered a thought leader in this space.
Marco Stief is a partner and the head of legal at Maiwald. He is an internationally recognised expert in the field of intellectual property and has extensive experience in advising clients in R&D projects and the negotiation of a wide variety of technology-related contracts, in particular cooperation, R&D and licence agreements. Mr Stief also regularly advises companies on complex IP transactions and in the field of patent infringement litigation.
For many consecutive years, IAM has listed Mr Stief among the world’s top 300 leading IP strategists, as well as among the world’s top 1000 leading patent professionals. He is mentioned in the German JUVE Handbook as one of the top eight German patent lawyers under the age of 50, emphasising that his clients, in particular, praise his pragmatic approach. In 2018, Mr Stief was admitted to the circle of the best six patent litigators in Germany by Who’s Who Legal. The German WirtschaftsWoche praised him as one of the best lawyers for IP law in Germany, and the Legal 500 recommends him as “pragmatic, fast, results-oriented and always meeting the highest professional standards”.
Mr Stief teaches IP law at the University of Dresden, as well as pharmaceutical, patent and international contract law at the University of Marburg.